Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pathologic Complete Response × Immunotherapy × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7 Head and Neck Neoplasms 6 Nasopharyngeal Carcinoma 2 Urogenital Neoplasms 1 Recurrence 1 Pathologic Complete Response 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Deglutition Disorders 1 Breast Neoplasms 1

Interventions

Radiotherapy 1 Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06811844 2025-07-01

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting

Pathologic Complete Response, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡